Commentary: Diagnostic medical radiation exposure in inflammatory bowel disease

Alimentary Pharmacology and Therapeutics

Volumn 35, Issue 8, 2012, Pages 959-960

  Levy, L C ^a   Siegel, C A ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ANTIBODY;

COMPUTER ASSISTED TOMOGRAPHY; CONFOUNDING VARIABLE; DEATH; DISEASE ASSOCIATION; DISEASE SEVERITY; ENTERITIS; HUMAN; IONIZING RADIATION; MORTALITY; NONHODGKIN LYMPHOMA; NOTE; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION EXPOSURE; RISK FACTOR;

DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; INFLAMMATORY BOWEL DISEASES; META-ANALYSIS AS TOPIC; NEOPLASMS, RADIATION-INDUCED; RADIATION INJURIES; RISK ASSESSMENT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84858784221     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2012.05035.x     Document Type: Note

References (6)

1. Chatu S, Subramanian V, Pollok RC,. Meta-analysis: diagnostic medical radiation exposure in inflammatory bowel disease. Aliment Pharmacol Ther 2012; 35: 529-39.
2. Hall EJ, Brenner DJ,. Cancer risks from diagnostic radiology. Br J Radiol 2008; 81: 362-78.
3. Peloquin JM, Pardi DS, Sandborn WJ, et al. Diagnostic ionizing radiation exposure in a population-based cohort of patients with inflammatory bowel disease. Am J Gastroenterol 2008; 103: 2015-22.
4. Brenner DJ, Hall EJ,. Computed tomography-an increasing source of radiation exposure. N Engl J Med 2007; 357: 2277-84.
5. Siegel CA, Marden SM, Persing SM, Larson RJ, Sands BE. Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis. Clin Gastroenterol Hepatol 2009; 7: 874-81.
6. Beaugerie L, Brousse N, Bouvier AM, et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet 2009; 374: 1617-25.